UK-based Reaxa and Switzerland’s RohnerChem have teamed up to develop the former’s EnCat catalyst technology for industrial applications in the API and drug manufacturing sector.
British chemical products and technologies firm Reaxa has launched
a new encapsulated catalyst for market trials. Platinum EnCat is a
platinum nanoparticle catalyst encapsulated within polymer beads,
intended for the hydrogenation...
Reaxa has chose the recent CphI to announce it is developing a new
addition to its range of scavenging resins that it claims allows a
huge reduction in product loss in the process of precious metals
clean-up.
Avecia spin-out Reaxa has launched a new peptide coupling
technology based on 2-mercaptobenzothiazole (2-MBT), which it
claims offers major operational and cost benefits in both small and
large scale solid-phase peptide synthesis.
Fine and specialty chemicals company Avecia is planning to spin out
part of its pharmaceutical technologies portfolio into a new
company to be called Reaxa. The move should complete before the end
of this quarter.